. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: Lancet Infect Dis. 2019 Feb 10;19(3):317–326. doi: 10.1016/S1473-3099(18)30655-8

Table 1.

HPV DNA type-specific number of detections and prevalence in valid hand samples and concomitant genital samples.

HPV group	Sex	Total HPV type detections (n)^a			HPV prevalence^b
		Hand	Genital	Either Hand or Genital	Hand (women N=479 men N=489)		Genital (women N=473 men N=483)
					n	(%)	n	(%)
Any	Women	300	748	805	170	35·5%	283	59·8%

	Men	352	903	959	178	36·4%	306	63·4%

HR^C	Women	126	326	344	95	19·8%	203	42·9%

	Men	143	356	384	105	21·5%	218	45·1%

LR^C	Women	126	291	317	99	20·7%	186	39·3%

	Men	135	386	399	101	20·7%	226	46·8%

HPV=Human papillomavirus; HR=high risk types; LR=low risk types; N=denominator.

Number of type-specific detections at all visits. Each individual may contribute multiple HPV type detections if samples are positive for multiple types.

Proportion of samples that are positive for any of the group’s HPV types across visits. Denominators (N) are the number of valid hand and genital samples over all visits.

HR: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68. LR: HPV 6, 11, 40, 42, 44, 54, 61, 62, 71, 72, 81, 83, 84, 89.